A panel of advisers to the Food and Drug Administration has recommended revising the current COVID-19 vaccine so that it specifically targets omicron.
Insurers, employers, taxpayers and other consumers will all be affected as drugmakers move these products to the commercial market in May. How much you'll pay depends on your health insurance.
Advisers to the U.S. Food and Drug Administration today endorsed a proposal to make big changes in the nation's approach to vaccinating people against COVID-19.
The new approach would simplify vaccination guidance so that, every fall, people would get a new shot, updated to try to match whatever variant is dominant.
CDC Director Rochelle Walensky has signed off on updated versions of the Moderna and Pfizer-BioNTech vaccines that target the original virus and the omicron subvariants.
The Biden administration is scrapping plans to offer COVID boosters for people under 50 this summer. Instead they will push for an earlier release of the next generation boosters in the fall.
The Food and Drug Administration expanded authorization of Pfizer-BioNTech's COVID vaccine to enable kids ages 5 to 11 who were vaccinated at least five months ago to get a third shot.
Now, both the Pfizer and the Moderna booster shots can be given five months after the second dose of vaccine — down from six months.
The move to shorten the Pfizer booster interval comes as the U.S. shatters daily case records. The recommended interval for those who received Moderna or Johnson & Johnson vaccines has not changed.
Scientists are projecting the surge will peak in January. Just how massive it could be depends on how quickly Americans get boosted and change behavior to slow the spread.
Plus: Is it safe to go to a holiday party if not everyone is vaccinated? And are people getting different side effects from the COVID booster?
In small studies in South Africa and in Germany, the results indicate a marked decrease in the ability of vaccines to neutralize this variant. But there are other findings that are encouraging.
Booster shots have been authorized for all U.S. adults, and the government is urging people to get them. But what if you've already had COVID and the vaccine?
CDC Director Rochelle Walensky gave the green light to boosters just hours after a panel of vaccine advisors voted unanimously to recommend boosters for anyone 18 and older.
The FDA on Friday granted emergency use authorization for the Pfizer-BioNTech and Moderna booster shots. The boosters have already been available for people 65 and older and to high-risk adults.